Literature DB >> 23940214

EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial.

R V Moerman1, S Arends, P M Meiners, E Brouwer, F K L Spijkervet, F G M Kroese, A Vissink, H Bootsma.   

Abstract

Entities:  

Keywords:  B cells; Disease Activity; SjÃgren's Syndrome

Mesh：

Substances：

Year:  2013        PMID： 23940214     DOI： 10.1136/annrheumdis-2013-203736

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Biomarkers: new biomarker for Sjögren's syndrome--time to treat patients.

Authors:  Frans G M Kroese; Hendrika Bootsma
Journal:  Nat Rev Rheumatol       Date:  2013-09-17       Impact factor: 20.543

2.  Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Authors:  Clare Oni; Sheryl Mitchell; Katherine James; Wan-Fai Ng; Bridget Griffiths; Victoria Hindmarsh; Elizabeth Price; Colin T Pease; Paul Emery; Peter Lanyon; Adrian Jones; Michele Bombardieri; Nurhan Sutcliffe; Costantino Pitzalis; John Hunter; Monica Gupta; John McLaren; Annie Cooper; Marian Regan; Ian Giles; David Isenberg; Vadivelu Saravanan; David Coady; Bhaskar Dasgupta; Neil McHugh; Steven Young-Min; Robert Moots; Nagui Gendi; Mohammed Akil; Francesca Barone; Ben Fisher; Saaeha Rauz; Andrea Richards; Simon J Bowman
Journal:  Rheumatology (Oxford)       Date:  2015-10-27       Impact factor: 7.580

3.  Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.

Authors:  Carl Cooper; Samantha Wratten; Rebecca Williams-Hall; Arthur A M Bookman; Briana Ndife; Wolfgang Hueber; Pushpendra Goswami
Journal:  Rheumatol Ther       Date:  2022-09-16

4.  Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Authors:  Valérie Devauchelle-Pensec; Jacques-Eric Gottenberg; Sandrine Jousse-Joulin; Jean-Marie Berthelot; Aleth Perdriger; Eric Hachulla; Pierre Yves Hatron; Xavier Puechal; Véronique Le Guern; Jean Sibilia; Laurent Chiche; Vincent Goeb; Olivier Vittecoq; Claire Larroche; Anne Laure Fauchais; Gilles Hayem; Jacques Morel; Charles Zarnitsky; Jean Jacques Dubost; Philippe Dieudé; Jacques Olivier Pers; Divi Cornec; Raphaele Seror; Xavier Mariette; Emmanuel Nowak; Alain Saraux
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

5.  Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.

Authors:  Ayumi Nishikawa; Katsuya Suzuki; Yoshiaki Kassai; Yuumi Gotou; Maiko Takiguchi; Takahiro Miyazaki; Keiko Yoshimoto; Hidekata Yasuoka; Kunihiro Yamaoka; Rimpei Morita; Akihiko Yoshimura; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2016-05-14       Impact factor: 5.156

Review 6.  EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Authors:  Raphaèle Seror; Simon J Bowman; Pilar Brito-Zeron; Elke Theander; Hendrika Bootsma; Athanasios Tzioufas; Jacques-Eric Gottenberg; Manel Ramos-Casals; Thomas Dörner; Philippe Ravaud; Claudio Vitali; Xavier Mariette; Karsten Asmussen; Soren Jacobsen; Elena Bartoloni; Roberto Gerli; Johannes Wj Bijlsma; Aike A Kruize; Stefano Bombardieri; Arthur Bookman; Cees Kallenberg; Petra Meiners; Johan G Brun; Roland Jonsson; Roberto Caporali; Steven Carsons; Salvatore De Vita; Nicoletta Del Papa; Valerie Devauchelle; Alain Saraux; Anne-Laure Fauchais; Jean Sibilia; Eric Hachulla; Gabor Illei; David Isenberg; Adrian Jones; Menelaos Manoussakis; Thomas Mandl; Lennart Jacobsson; Frederic Demoulins; Carlomaurizio Montecucco; Wan-Fai Ng; Sumusu Nishiyama; Roald Omdal; Ann Parke; Sonja Praprotnik; Matjia Tomsic; Elizabeth Price; Hal Scofield; Kathy L Sivils; Josef Smolen; Roser Solans Laqué; Serge Steinfeld; Nurhan Sutcliffe; Takayuki Sumida; Guido Valesini; Valeria Valim; Frederick B Vivino; Cristina Vollenweider
Journal:  RMD Open       Date:  2015-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.